Lluis M Mir Selected Research

Lluis M Mir Research Topics

Disease

24	Neoplasms (Cancer) 01/2020 - 10/2003
6	Neoplasm Metastasis (Metastasis) 10/2017 - 12/2006
5	Melanoma (Melanoma, Malignant) 11/2017 - 04/2009
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 01/2014
1	Neuroblastoma 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Fever (Fevers) 09/2013
1	Ductal Carcinoma 09/2012
1	Experimental Melanoma 08/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2011
1	Hyperthermia 04/2008
1	Hypoxia (Hypoxemia) 12/2006
1	Carcinoma (Carcinomatosis) 12/2003

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2016 - 10/2003
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 10/2003
3	Norisoprenoids (Irones)IBA 10/2017 - 01/2014
3	Odorant Receptors (Odorant Receptor)IBA 10/2017 - 01/2014
3	LigandsIBA 01/2017 - 09/2008
3	Cisplatin (Platino)FDA LinkGeneric 09/2012 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2013
2	AntigensIBA 01/2014 - 09/2008
2	VaccinesIBA 01/2014 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 08/2011 - 12/2006
1	Biological ProductsIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	Chemokine ReceptorsIBA 11/2017
1	Chimeric Antigen ReceptorsIBA 11/2017
1	galleinIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2016
1	CytokinesIBA 01/2016
1	CalreticulinIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2014
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2014
1	HMGB1 Protein (HMG1)IBA 01/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2014
1	ORALIT (ORS)IBA 01/2014
1	DNA VaccinesIBA 01/2014
1	1-aminomethylphosphonic acidIBA 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	C-Reactive ProteinIBA 09/2013
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 03/2013
1	Cobalt-60IBA 09/2012
1	LuciferasesIBA 08/2011
1	IntegrinsIBA 08/2011
1	DisintegrinsIBA 08/2011
1	Thrombospondin 1IBA 08/2011
1	Protein Isoforms (Isoforms)IBA 08/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2011
1	CaveolinsIBA 04/2009
1	lucifer yellowIBA 04/2009
1	ClathrinIBA 04/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2008
1	CPG-oligonucleotideIBA 09/2008
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 09/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2008
1	OligodeoxyribonucleotidesIBA 09/2008
1	Interferon-alpha (Interferon Alfa)IBA 04/2008
1	AngiopoietinsIBA 12/2006
1	ElementsIBA 08/2005

Therapy/Procedure

5	Therapeutics 01/2020 - 09/2008
3	Electrodes (Electrode) 11/2008 - 11/2007
2	Immunotherapy 11/2017 - 01/2016
2	Radiotherapy 09/2012 - 04/2008
2	Drug Therapy (Chemotherapy) 04/2008 - 02/2007
1	Intraperitoneal Injections 10/2017
1	Palliative Care (Palliative Therapy) 01/2016
1	Aftercare (After-Treatment) 08/2011
1	Heterologous Transplantation (Xenotransplantation) 01/2011